Cargando…
N-acetyl Cysteine Administration Is Associated With Increased Cerebral Glucose Metabolism in Patients With Multiple Sclerosis: An Exploratory Study
Background: Multiple Sclerosis (MS) is an autoimmune disease marked by progressive neurocognitive injury. Treatment options affording neuroprotective effects remain largely experimental. The purpose of this proof of concept study was to explore the effects of N-acetyl-cysteine (NAC) on cerebral gluc...
Autores principales: | Monti, Daniel A., Zabrecky, George, Leist, Thomas P., Wintering, Nancy, Bazzan, Anthony J., Zhan, Tingting, Newberg, Andrew B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7033492/ https://www.ncbi.nlm.nih.gov/pubmed/32117038 http://dx.doi.org/10.3389/fneur.2020.00088 |
Ejemplares similares
-
N-acetyl cysteine administration affects cerebral blood flow as measured by arterial spin labeling MRI in patients with multiple sclerosis
por: Shahrampour, Shiva, et al.
Publicado: (2021) -
Retrospective Evaluation of Clinical Experience With Intravenous Ascorbic Acid in Patients With Cancer
por: Bazzan, Anthony J., et al.
Publicado: (2018) -
N-Acetyl Cysteine May Support Dopamine Neurons in Parkinson's Disease: Preliminary Clinical and Cell Line Data
por: Monti, Daniel A., et al.
Publicado: (2016) -
Alterations in cerebral glucose metabolism as measured by (18)F-fluorodeoxyglucose-PET in patients with persistent postconcussion syndrome
por: Teichner, Eric M., et al.
Publicado: (2021) -
Resting-State Functional MRI Metrics in Patients With Chronic Mild Traumatic Brain Injury and Their Association With Clinical Cognitive Performance
por: Vedaei, Faezeh, et al.
Publicado: (2021)